COMMUNIQUÉS West-GlobeNewswire

Aclaris Therapeutics to Present at the 2018 American Hair Research Summit
11/05/2018
WAYNE, Pa., May 11, 2018 (GLOBE NEWSWIRE) -- Paul Changelian, Ph.D., Vice President, Biology, Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), will speak at the 2018 American Hair Research Summit on “Preclinical to Clinical [...]
Trillium Therapeutics Reports First Quarter 2018 Financial and Operating Results
11/05/2018
Focusing TTI-621 clinical development on T-cell lymphoma TTI-621 received Orphan Drug Designation for the treatment of cutaneous T-cell lymphoma Preclinical data with TTI-622 (SIRPaFc IgG4) presented at AACR; cleared to [...]
Surgery Partners, Inc. to Present at Upcoming Investor Conferences
11/05/2018
NASHVILLE, Tenn., May 11, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) (“Surgery Partners”), a leading healthcare services company, today announced that management will present at the following [...]
Leap Therapeutics Reports First Quarter 2018 Financial Results
11/05/2018
Conference Call with DKN-01 Clinical Investigators Planned for May 18, 2018 CAMBRIDGE, Mass., May 11, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and [...]
Oncolytics Biotech® Reports 2018 First Quarter Results
11/05/2018
CALGARY, Alberta and SAN DIEGO, May 11, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX: ONC ) (OTCQX:ONCYF), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
PLx Pharma Inc. Reports First Quarter 2018 Results
11/05/2018
HOUSTON, May 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP ) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 [...]
Achillion Announces Upcoming Scientific Presentations at the 55th ERA-EDTA Congress
11/05/2018
- Oral presentation discussing ACH-4471 and interim biomarker data from the ongoing 14-day Phase 2 study in C3G - - Poster presentation detailing in vitro data showing no significant reduction in serum bactericidal [...]
Shire plc : Rule 2.9 Announcement
11/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 11 May 2018 Shire [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
11/05/2018
REGULATED INFORMATION GHENT, Belgium, 11 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/05/2018
SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent [...]
FDA Advisory Committee Votes in Favor of WAYLIVRA for Treatment of Familial Chylomicronemia Syndrome
11/05/2018
Advisory Committee members vote 12-8 to support approval CAMBRIDGE, Mass. and CARLSBAD, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., and [...]
Coherus BioSciences Reports Corporate Highlights and First Quarter 2018 Financial Results
10/05/2018
REDWOOD CITY, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today reviewed corporate highlights and reported financial results for the quarter ended March 31, 2018. First Quarter [...]
Jamieson Wellness Inc. Announces Voting Results from 2018 Annual Meeting of Shareholders
11/05/2018
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“ Jamieson Wellness ” or the “ Company ”) (TSX: JWEL ) announced today that each of the nominee directors listed in the management information circular [...]
Adamis Pharmaceuticals Announces First Quarter 2018 Financial Results and Business Update
10/05/2018
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) today announced financial results and a business update for the first quarter ended March 31, 2018. Dr. Dennis J. Carlo, [...]
Carrie Arran Resources Inc. and Fleurish Cannabis Inc. Announce Extension of Definitive Agreement Relating to Reverse Takeover Transaction
10/05/2018
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Carrie Arran Resources Inc. ("Carrie Arran") announces that it has extended the expiry date of the definitive agreement with Fleurish Cannabis Inc. ("Fleurish Cannabis") ( [...]
Sienna Senior Living Inc. Reports 2018 First Quarter Financial Results
10/05/2018
MARKHAM, Ontario, May 10, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) today announced its financial results for the three months ended March 31, 2018. The Unaudited [...]
Aclaris Therapeutics to Attend Upcoming Investor Conferences
10/05/2018
WAYNE, Pa., May 10, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
Extendicare Announces 2018 First Quarter Results
10/05/2018
MARKHAM, Ontario, May 10, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today reported results for the three months ended March 31, 2018. Results are presented in Canadian [...]
Emergent BioSolutions to Hold Annual Meeting of Stockholders on Thursday, May 24, 2018 at 9:00 AM EDT; Webcast Will Be Available
10/05/2018
GAITHERSBURG, Md., May 10, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 24, 2018 beginning at 9:00 AM EDT at the [...]

Pages